Stryker Net Profit Margin 2010-2024 | SYK
Current and historical net profit margin for Stryker (SYK) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Stryker net profit margin for the three months ending December 31, 2024 was .
| Stryker Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $22.60B | $2.99B | 13.25% |
| 2024-09-30 | $21.97B | $3.59B | 16.34% |
| 2024-06-30 | $21.39B | $3.45B | 16.12% |
| 2024-03-31 | $20.96B | $3.36B | 16.03% |
| 2023-12-31 | $20.50B | $3.17B | 15.44% |
| 2023-09-30 | $19.89B | $2.59B | 13.00% |
| 2023-06-30 | $19.46B | $2.71B | 13.92% |
| 2023-03-31 | $18.95B | $2.63B | 13.86% |
| 2022-12-31 | $18.45B | $2.36B | 12.78% |
| 2022-09-30 | $17.95B | $2.46B | 13.69% |
| 2022-06-30 | $17.63B | $2.08B | 11.79% |
| 2022-03-31 | $17.43B | $2.02B | 11.56% |
| 2021-12-31 | $17.11B | $1.99B | 11.66% |
| 2021-09-30 | $16.67B | $1.90B | 11.40% |
| 2021-06-30 | $16.25B | $2.08B | 12.82% |
| 2021-03-31 | $14.72B | $1.41B | 9.57% |
| 2020-12-31 | $14.35B | $1.60B | 11.14% |
| 2020-09-30 | $14.22B | $1.76B | 12.35% |
| 2020-06-30 | $14.07B | $1.60B | 11.38% |
| 2020-03-31 | $14.96B | $2.16B | 14.47% |
| 2019-12-31 | $14.88B | $2.08B | 13.99% |
| 2019-09-30 | $14.55B | $3.43B | 23.55% |
| 2019-06-30 | $14.20B | $3.55B | 24.99% |
| 2019-03-31 | $13.88B | $3.52B | 25.38% |
| 2018-12-31 | $13.60B | $3.55B | 26.12% |
| 2018-09-30 | $13.28B | $1.24B | 9.31% |
| 2018-06-30 | $13.04B | $1.08B | 8.28% |
| 2018-03-31 | $12.73B | $1.02B | 8.00% |
| 2017-12-31 | $12.44B | $1.02B | 8.20% |
| 2017-09-30 | $12.13B | $1.78B | 14.67% |
| 2017-06-30 | $11.96B | $1.70B | 14.22% |
| 2017-03-31 | $11.79B | $1.69B | 14.33% |
| 2016-12-31 | $11.33B | $1.65B | 14.54% |
| 2016-09-30 | $10.88B | $1.66B | 15.24% |
| 2016-06-30 | $10.47B | $1.61B | 15.33% |
| 2016-03-31 | $10.06B | $1.62B | 16.07% |
| 2015-12-31 | $9.95B | $1.44B | 14.47% |
| 2015-09-30 | $9.85B | $1.18B | 11.95% |
| 2015-06-30 | $9.82B | $0.93B | 9.50% |
| 2015-03-31 | $9.75B | $0.67B | 6.86% |
| 2014-12-31 | $9.68B | $0.52B | 5.32% |
| 2014-09-30 | $9.53B | $0.64B | 6.73% |
| 2014-06-30 | $9.29B | $0.69B | 7.40% |
| 2014-03-31 | $9.14B | $0.77B | 8.45% |
| 2013-12-31 | $9.02B | $1.01B | 11.15% |
| 2013-09-30 | $8.89B | $0.89B | 10.01% |
| 2013-06-30 | $8.79B | $1.14B | 12.97% |
| 2013-03-31 | $8.69B | $1.25B | 14.41% |
| 2012-12-31 | $8.66B | $1.30B | 14.99% |
| 2012-09-30 | $8.53B | $1.43B | 16.74% |
| 2012-06-30 | $8.51B | $1.40B | 16.48% |
| 2012-03-31 | $8.45B | $1.39B | 16.42% |
| 2011-12-31 | $8.31B | $1.35B | 16.19% |
| 2011-09-30 | $8.09B | $1.24B | 15.32% |
| 2011-06-30 | $7.82B | $1.25B | 15.96% |
| 2011-03-31 | $7.54B | $1.26B | 16.69% |
| 2010-12-31 | $7.32B | $1.27B | 17.39% |
| 2010-09-30 | $7.16B | $1.28B | 17.94% |
| 2010-06-30 | $7.04B | $1.18B | 16.70% |
| 2010-03-31 | $6.92B | $1.15B | 16.59% |
| 2009-12-31 | $6.72B | $1.11B | 16.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $144.095B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Medtronic (MDT) | Ireland | $105.579B | 15.42 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.255B | 11.72 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.16 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |